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OBJECTIVES This study examined the roles of myocardial perfusion and adenosine in warm-up angina.
BACKGROUND In warm-up angina, neither the role of an adenosine-mediated mechanism, as is found in
experimental ischemic preconditioning, nor of increased myocardial perfusion is well defined.
METHODS In substudy A, a single-photon emission computed tomography (SPECT)-thallium-201
exercise test was performed by 12 subjects with ischemic heart disease on three occasions one
week apart. The third test was preceded by a warm-up test. The extent of the thallium deficit
and its intensity on the third test were compared with the baseline tests controlling for the
heart rate-systolic blood pressure product (RPP) at thallium injection. In substudy B, 12
similar subjects did two successive exercise tests at two separate sessions and received the
adenosine antagonist, aminophylline (intravenous 5 mg/kg bolus and 0.9 mg/kg/h infusion)
at one session, and equivalent saline at the other session. Change in ischemic threshold (RPP
at 1 mm ST segment depression) and in maximum ST depression adjusted for RPP were
analyzed.
RESULTS In substudy A, despite a significant attenuation of electrocardiogram indexes of myocardial
ischemia between the baseline and third (warmed-up) tests, the thallium extent deficits
(20.8 6 15.1% and 16.8 6 12.4%) and intensity deficits (41.2 6 12.6% and 39.3 6 12.6%)
did not differ significantly. In substudy B, the increase in ischemic threshold on re-exercise
was unaffected by aminophylline. Adjusted maximum ST depression even decreased to a
greater extent on re-exercise with aminophylline (by 51 6 21%) than with saline (by 32 6
19%) (p 5 0.012).
CONCLUSIONS While warm-up angina is associated with a significant attenuation of exercise electrocardio-
gram indexes of ischemia, it is unaccompanied by significant changes in SPECT perfusion
and does not appear to be mediated by an adenosine-dependent mechanism since it is not
blocked by aminophylline. Thus, its mechanism, which appears distinct from experimental
ischemic preconditioning, remains unidentified. (J Am Coll Cardiol 2001;37:463–9) © 2001
by the American College of Cardiology
Warm-up angina is an intriguing phenomenon whereby, in
subjects with coronary artery disease (CAD), the angina
induced by initial exercise is attenuated, or even disappears,
if they briefly slacken or interrupt their exertion before
resuming it at the same or an even greater level of intensity
(1–7). This attenuation of myocardial ischemia can be
objectified using a protocol of two exercise electrocardio-
graphic (ECG) tests separated by a brief rest (4–7). Its
underlying mechanism is undefined. This ischemia-sparing
phenomenon does not appear to be associated with down-
regulation or stunning of left ventricular contractile func-
tion, variations in adrenergic tone or activation of adenosine
triphosphate-sensitive potassium channels (K1-ATP) (7).
It has been speculated that it could be analagous to
experimental ischemic preconditioning in which, in animal
models, brief coronary artery occlusion preceding sustained
occlusion, followed by timely reperfusion, can considerably
reduce infarct size (8). In humans in a variant of this model,
during coronary angioplasty, brief inflations of the balloon
catheter before longer inflation attenuate ECG and other
manifestations of myocardial ischemia (9,10). In experi-
mental ischemic preconditioning and its human variant,
adenosine has been identified as a key mediator, but the role
of increased myocardial perfusion through the collateral
circulation is controversial (10–16). Therefore, to explore
the underlying mechanism and the relationship, if any, with
experimental ischemic preconditioning, this study evaluated
the roles in warm-up angina of adenosine and of myocardial
perfusion, as determined by single-photon emission com-
puted tomography (SPECT) using thallium-201 (Tl-201).
METHODS
This study consisted of two substudies. Substudy A evalu-
ated the role of myocardial perfusion in warm-up angina
using SPECT; substudy B examined the role of adenosine
using the nonspecific adenosine receptor antagonist, ami-
nophylline. All 21 subjects in this study had to have: 1)
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stable angina; 2) documentation of CAD with coronary
angiography ($70% coronary artery stenosis) in 13 subjects
and with Tl-201 myocardial perfusion imaging (significant
reversible hypoperfusion) in 8 subjects; 3) a previous positive
ECG exercise test ($1 mm ST segment depression 80 ms
after the J point compared with the baseline ST segment);
and 4) a resting ECG without left ventricular hypertrophy,
conduction abnormality or ST segment deviation $1 mm.
All subjects were in normal sinus rhythm. In addition, in
order to optimize interpretation of the myocardial perfusion
scans, all subjects in substudy A had to have documented
normal left ventricular contractility, an effort-induced Tl-
201 deficit of at least 10% (see subsequent text) and a
redistribution Tl-201 scan within normal limits (not sug-
gestive of prior myocardial infarction). All subjects had
previously performed several reproducible exercise tests and
were well familiar with this procedure. Each substudy
involved 12 subjects; three subjects participated in both
substudies. The hospital institutional review board approved
both substudies, and all patients gave written informed
consent.
Exercise ECG protocol. In both substudies, beta-blocking
and calcium antagonist drugs were stopped at least 48 h and
nitrates at least 12 h before testing. No patients were taking
digitalis. All tests in substudy A were performed in mid-
morning in the fasting state and all tests in substudy B in
midafternoon at least 2 h postprandially and with no
consumption of caffeinated beverages that day. Subjects
were instructed to refrain from exercise or unusual exertion
and not to smoke that day prior to exercise testing. In both
substudies, the symptom-limited modified Bruce protocol
was used on a Q65 treadmill linked to a Q4000 monitor
(Quinton Instrument Co., Seattle, Washington). The ECG
was continuously monitored. A standard 12-lead ECG was
taken in the resting, supine and standing positions and then
every 30 s during exercise and recovery, which was in the
sitting position. Each time, both an averaged and a raw data
ECG were obtained. Blood pressure was obtained with a
mercury sphygmomanometer every 2 min and at peak
exercise. Indications for stopping the exercise test were
uncomfortable dyspnea or angina (always aiming for the
same discomfort score of 7/10 on a visual scale), a drop in
blood pressure .10 mm Hg or a serious arrhythmia. The
ECG display screen was shielded such that both subject and
medical supervisor were blinded to exercise duration. The
same physician supervised all tests. The warm-up protocol
involved two successive exercise tests separated by an inter-
val of about 10 min, which depended on subjects’ willing-
ness to re-exercise and return of the ST segment to its
original resting baseline (7). The second exercise is referred
to as the warmed-up test.
The exercise test was considered positive at first appear-
ance of sustained 1 mm ST segment depression 80 ms after
the J point, compared with the resting ECG taken in the
standing position just before exercise. The raw data and
averaged tracings were examined for consistency requiring
three consecutive beats with similar findings. The time of
onset of exercise test positivity and the corresponding heart
rate-systolic blood pressure product (RPP) or ischemic
threshold were noted as was the time of onset of angina.
Maximum ST segment depression was noted on raw data
and averaged tracings taken at peak exercise. When a
warmed-up exercise ECG test was compared with a baseline
test, adjusted maximum ST segment depression was also
analyzed (7). This was the amount of ST segment depres-
sion (STD) at or near peak exercise corresponding to the
highest RPP common to both exercises. ST segment recov-
ery time was from end-exercise to the final appearance of
1 mm STD. Since T wave inversion often occurs during
recovery and appears to drag down the ST segment, the
latter was carefully scrutinized, and, if it rose during recov-
ery to less than 1 mm depression only to subsequently drop
down with T wave inversion, this latter change was not
considered as recovery time (17). After all patients had been
studied, exercise tracings were analyzed independently by
two examiners, unaware whether the exercise test was a
baseline or a warmed-up test, and differences were resolved
by consensus. Only the evaluation of adjusted maximum
STD was, of necessity, performed after unblinding.
Substudy A: Nuclear imaging protocol and data analysis.
Subjects were studied at three separate sessions one to three
weeks apart. At the first session, they performed a single
symptom-limited exercise Tl-201 SPECT test. One minute
before the anticipated end of exercise, 3.0 mCi (111 MBq)
of Tl-201 was injected intravenously and flushed with
10-ml saline. At the second session, they performed another
such test except that Tl-201 was administered at the RPP,
which was as close as possible to that of the Tl-201 injection
at the first session; the test was terminated 1 min later. The
Tl-201 exercise tests of these first two baseline sessions
established inter-test variability. At the third session, sub-
jects performed the two successive exercise tests of the
warm-up protocol with Tl-201 administered at the
warmed-up test, again at a RPP that was as close as possible
to that at Tl-201 injection in the baseline tests. This
warmed-up test was also terminated 1 min after injection.
The findings of the warmed-up test were compared with
those of the baseline test with the closest RPP at Tl-201
injection. Recovery time was truncated at 2 min in this
substudy because of the need to proceed with the scinti-
Abbreviations and Acronyms
CAD 5 coronary artery disease
ECG 5 electrocardiographic, electrocardiogram
K1-ATP 5 adenosine triphosphate-sensitive potassium
channel(s)
RPP 5 heart rate-systolic blood pressure product
SPECT 5 single-photon emission computed
tomography (or tomographic)
STD 5 ST segment depression
Tl-201 5 thallium-201
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graphic imaging protocol. Subjects were then taken by
wheelchair within 5 min to the scintigraphic imaging camera.
A 5-min planar anterior view was first obtained within
10 min of injection, followed by SPECT imaging per-
formed on a large field-of-view single head rotation gamma
camera with a 0.37-inch thick sodium iodide crystal and 65
photomultiplier tubes (Siemens Orbiter, Chicago, Illinois)
equipped with a low energy all-purpose parallel hole colli-
mator. The system was linked to a Siemens Microdelta
computer. A 20% energy window centered on the 80 Kev
x-ray peak and a 10% window centered on the 167 Kev
gamma-ray peak were used. Sixty-four 20-s projections
were acquired over a 180° arc, extending from the 45° right
anterior oblique to the 45° left posterior position using a
circular orbit. Data were stored in a 64 3 64 16-bit (word)
matrix. Field-nonuniformity and center-of-rotation offset
corrections were performed before reconstruction. A But-
terworth filter with 0.4 cutoff and an order of 5.0 was used
for processing the raw data after prereconstruction interslice
averaging using a 0.25, 0.50, 0.25 weighting array. Sections
were reconstructed in short, vertical-long and horizontal-
long axes.
Redistribution imaging was performed 4 h after Tl-201
injection using the same parameters of acquisition and
reconstruction without reinjection of Tl-201. After recon-
struction, all images were checked and realigned, if neces-
sary, for appropriate registration of stress and redistribution
images in each plane. Two-dimensional polar map display
representing extent and severity of disease were generated
for the initial tomograms and delayed tomograms using
commercially available software (18,19).
One pixel thick (6 mm) contiguous slices were added
together in the three axes to obtain 2 pixel thick (12 mm)
slices. After visual inspection and qualitative appreciation of
myocardial perfusion defects, the severity of disease was
characterized as the ischemic/normal wall ratio obtained
from circumferential profiles on the slice showing the most
severe Tl-201 perfusion defect (maximum deficit). The
extent of the perfusion abnormality was evaluated by the
percentage of abnormal myocardium on extent polar map
display. These methods of measuring the extent and severity
of myocardial ischemia have been validated previously (18–
20). All scintigrams were evaluated by a single experienced
specialist in cardiac nuclear medicine unaware of the pa-
tients’ other clinical data. In all cases, Tl-201 heart/lung
uptake ratios were assessed from stress and redistribution
planar views to rule out any possible underestimation of
disease severity due to diffuse multivessel disease. Subjects
were eliminated from analysis after the initial control study
if the maximum severity deficit was ,20% or the extent
deficit was ,10% because of the difficulty in such subjects of
measuring a possibly significant difference from findings on
the warmed-up test.
Substudy B protocol. In this protocol, subjects came to
two exercise test sessions one to four weeks apart. At each
session, they performed the two successive ECG exercise
tests of the warm-up protocol. The interval between the two
tests of the first session was kept identical at the second
session. At each session, intravenous access was secured,
and, in double-blind fashion and in random order, at one
session, aminophylline, the ethylenediamine salt of theoph-
ylline, was administered as a 5 mg/kg intravenous bolus over
5 min followed by a 0.9 mg/kg/h intravenous infusion, and,
at the other session, equivalent saline was given. The first
exercise test was commenced after bolus drug administra-
tion and the infusion stopped at the end of the recovery
period of the second test. Serum theophylline was measured
at that time using a homogeneous enzyme immunological
assay (Cedia) on a Hitachi 917 apparatus (Roche Diagnos-
tics, Laval, Quebec). All ECG tracings were analyzed
blinded to aminophylline versus saline administration and to
the order of the tests, as already described.
Statistical analysis. Values are expressed as means 6
standard deviation. The paired Student t-test was used to
compare intrasession and intersession exercise ECG and
scintigraphic parameters. Data for substudy B comparing
saline to aminophylline were analyzed using a two-way
repeated-measures analysis of variance. Relationships be-
tween serum theophylline levels and changes in the ischemic
threshold and in adjusted maximum STD from the first to
the second exercise were evaluated using Pearson’s correla-
tion coefficients. A p value #0.05 was considered statisti-
cally significant. Data were analyzed using the statistical
package SAS (SAS Institute Inc., Cary, North Carolina).
RESULTS
Substudy A. The 11 men and one woman of this substudy
were aged 55 6 8 years. Three patients had single-vessel
angiographic coronary disease or single-region disease by
scintigraphic imaging, and nine patients had multivessel or
multiregion disease. Exercise duration and workload
achieved in the baseline test used in the comparative analysis
were 11.2 6 2.8 min and 8.9 6 2.6 metabolic equivalent
units, respectively. The ischemic threshold (31023) in-
creased from 17.3 6 3.6 in the baseline test to 20.0 6 3.9
in the warmed-up test, an increase of 16.5 6 12.5% (p 5
0.002) in 10/12 subjects (Fig. 1). This parameter could not
be analyzed in the remaining two subjects because their
warmed-up tests were negative, and peak RPP in their
warmed-up tests was below the ischemic threshold of their
baseline tests. The adjusted maximum STD decreased by
28.9 6 38.6% from 3.1 6 1.5 mm in the baseline test to
2.0 6 1.2 mm in the warmed-up test (p 5 0.015) (Fig. 1).
The variability in the ischemic extent score between the
two baseline tests was 6.9 6 3.7% and was established by
comparing the extent deficits in the two baseline tests of
those subjects (6 of the 12 subjects studied) whose RPPs at
Tl-201 injection differed by less than 5% (1.3 6 1.4%). The
mean difference in RPPs at Tl-201 injection between the
baseline tests and the warmed-up tests was minor at 3.8 6
1.9%. Since myocardial oxygen consumption at Tl-201
465JACC Vol. 37, No. 2, 2001 Bogaty et al.
February 2001:463–9 Myocardial Ischemia Perfusion and Adenosine in Warm-up Angina
injection could, thus, be assumed to be quite similar, the
myocardial scintigrams of the two tests could be compared.
The extent deficit of the baseline test was 20.8 6 15.1% and
was 16.8 6 12.4% in the warmed-up test (p 5 0.11) (Fig.
2). This difference (6.6 6 5.9%) was within the inter-test
variability established by analysis of baseline tests. As for the
maximum deficit, there was no significant difference in this
scintigraphic parameter between the baseline test (41.2 6
12.6%) and the warmed-up test (39.3 6 12.6%) (Fig. 2).
Substudy B. The 10 men and 2 women of this substudy
were aged 62 6 7 years. Seven patients had single-vessel
coronary disease or single-region disease by scintigraphic
imaging, and five patients had multivessel or multiregion
disease. All had normal left ventricular contractility. Inter-
test time at both sessions was 11 6 3 min. Serum theoph-
ylline was 30.1 6 10.3 mmol/L. Electrocardiogram exercise
parameters are summarized in Table 1. The slightly more
prolonged exercise time at exercise 2 compared with exercise
1 was no longer observed with aminophylline. Heart rate-
systolic blood pressure product at rest and at peak exercise
was higher at exercise 2 compared with exercise 1 with and
without aminophylline. Heart rate-systolic blood pressure
product at rest tended to be higher with aminophylline than
with saline at exercise 1 (p 5 0.09) and was higher at
exercise 2 (p 5 0.04); RPP at peak exercise was higher with
aminophylline than it was with saline (p 5 0.01). While
time to angina was slightly longer at exercise 2 compared
with exercise 1 with saline, there was no change with
aminophylline. Maximum STD and recovery time both
decreased at exercise 2, and this was unaffected by aminoph-
ylline. With aminophylline, the ischemic threshold at exer-
cise 1 was 13 6 16% higher than the level observed with
saline (p 5 0.016) (Fig. 3). However, whereas the ischemic
threshold (31023) increased significantly at exercise 2 from
22.1 6 4.2 to 25.5 6 5.3 with saline (p , 0.001), a similar
increase was also observed from 25.0 6 5.9 to 28.3 6 6.1
(p , 0.001) with aminophylline. Nor was there a correlation
between serum theophylline levels and any change in
ischemic threshold from exercise 1 to exercise 2 (r 5 0.02,
p 5 1.0). The adjusted maximum STD decreased markedly
at exercise 2 compared with exercise 1 with saline (2.6 6 0.8
to 1.8 6 0.8 mm, p , 0.001) as with aminophylline (2.5 6
1.0 to 1.3 6 1.0 mm, p , 0.001) (Fig. 4). Interestingly, the
degree of attenuation of this parameter was even greater
Figure 2. The myocardial Tl-201 percent extent and percent maximum deficit perfusion defects at exercises 1 and 2 in substudy A. Exercise 1 is the baseline
exercise Tl-201 test, which was used in the analysis, and exercise 2 is the warmed-up Tl-201 test of the third exercise session. Tl-201 5 thallium-201.
Figure 1. The ischemic threshold and the adjusted maximum (max) ST segment depression in exercises 1 and 2 of the scintigraphic study (substudy A).
The ischemic threshold is the heart rate-systolic blood pressure product 3 1023 at the appearance of 1 mm ST segment depression. Adjusted max ST
depression is the maximum ST segment depression corresponding to the highest heart rate-systolic blood pressure product common to both exercises.
Exercise 1 is the baseline exercise electrocardiogram Tl-201 test, which was used in the analysis, and exercise 2 is the warmed-up Tl-201 test of the third
exercise session. Tl-201 5 thallium-201.
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with aminophylline (51 6 21% versus 32 6 19%, p 5
0.012). There was no correlation between serum theophyl-
line levels and the change in adjusted maximum STD from
exercise 1 to exercise 2 (r 5 0.06, p 5 0.8).
DISCUSSION
The principal findings of this study are: 1) the attenuation of
myocardial ischemia observed with repeated exercise is not
accounted for by an improvement in myocardial perfusion as
determined by Tl-201 SPECT imaging, and 2) this phe-
nomenon does not appear to be mediated by an adenosine-
dependent mechanism.
Warm-up angina and myocardial perfusion. The physi-
ologic basis of warm-up angina is unexplained, and few
studies have explored potential mechanisms. Whereas an
increase in coronary perfusion has been suggested (1–
3,21,22), two studies using serial exercise testing and con-
secutive cardiac pacing protocols, respectively, and measur-
ing coronary flow with great cardiac vein cannulation and
thermodilution did not show increased flow (23,24). Be-
cause of the limitations of this technique of evaluating
regional myocardial flow, we used Tl-201 SPECT imaging
to further characterize this phenomenon. Despite the well-
established superior sensitivity of perfusion scintigraphy
compared with the exercise ECG for the detection of
myocardial ischemia and despite the significant attenuation
of the ECG parameters of myocardial ischemia on re-
exercise, controlling for estimated myocardial oxygen con-
sumption by correction for RPP, we found no correspond-
ing significant modification of scintigraphic myocardial
perfusion findings.
Warm-up angina and adenosine. It has been suggested
that the attenuation of ischemia with repeated exercise is a
form of ischemic preconditioning whereby myocardium
subjected to brief coronary artery occlusions becomes con-
ditioned to better withstand subsequent more severe isch-
emia (8). Adenosine has been identified as a key mediator of
this phenomenon (11–14). Bamiphylline, a selective A1
adenosine receptor antagonist, does not blunt the warm-up
phenomenon (25). However, adenosine might mediate the
warm-up phenomenon via receptors other than the A1
receptor subtype. A recent study, using serial exercise testing
and blinded administration of aminophylline, a nonselective
Figure 3. Ischemic thresholds of ex 1 and 2 at the 2 ex sessions. Subjects
received intravenous saline at one session and intravenous aminophylline at
the other session. See Figure 1 and text for definition of the ischemic
threshold. *Aminophylline at ex 1 versus saline at ex 1, p 5 0.016. ex 5
exercise.
Figure 4. Adjusted maximum (max) ST segment depression of ex 1 and 2
at the saline and aminophylline exercise electrocardiogram sessions. See
Figure 2 and text for definition of adjusted maximum ST depression. ex 5
exercise. *Decrease in adjusted max ST depression from ex 1 to ex 2 with
aminophylline compared with decrease with saline, p 5 0.012.
Table 1. Exercise ECG Parameters in Substudy B
Saline Aminophylline
Ex 1 Ex 2 p Value Ex 1 Ex 2 p Value
Exercise time (min) 11.5 6 2.0 12.1 6 1.7 0.03 11.8 6 1.5 12.0 6 1.6 0.4
Exercise workload (METS) 10.5 6 2.1 10.3 6 1.5 0.6 11.3 6 1.4 10.8 6 1.3 0.2
RPP 3 1023 at rest 11.7 6 2.8 13.2 6 2.4 0.02 13.3 6 3.5 14.6 6 2.5* 0.07
RPP 3 1023 peak exercise 26.7 6 3.8 28.4 6 3.8 0.02 29.2 6 4.3† 31.3 6 4.0‡ 0.002
Time to angina (min)§ 8.5 6 2.5 9.4 6 2.4 0.04 9.5 6 2.5 9.5 6 3.2 1.0
Max ST depression (mm) 2.6 6 0.8 2.1 6 0.6 0.002 2.5 6 1.0 2.1 6 1.1 0.02
Recovery time (min) 2.8 6 3.6 1.7 6 2.6 0.01 2.8 6 3.5 1.4 6 2.4 0.02
*p 5 0.4 vs. Ex 2 saline; †p 5 0.005 vs. Ex 1 saline; ‡p , 0.001 vs. Ex 2 saline; §no angina in six subjects with saline and in five subjects with aminophylline.
Ex 5 exercise; min 5 minutes; METS 5 metabolic equivalent units; RPP 5 heart rate–systolic pressure product; Max 5 maximum.
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adenosine antagonist, has suggested that the warm-up
phenomenon is not adenosine-dependent (26). Aminoph-
ylline was given as a 3-mg/kg bolus without a subsequent
intravenous infusion. Exercise did not appear to be truly
symptom-limited, and inter-test time was relatively long at
20 min. Myocardial ischemia as judged by maximum STD
was modest (1.67 6 0.59 mm), as was the attenuation of
ischemia on re-exercise as judged by the increase in ischemic
threshold (about 5%) and, contrary to placebo, there was no
longer a significant change in the ischemic threshold and in
maximum STD with re-exercise when aminophylline was
administered. Thus, the findings of that study were not
unequivocal in ruling out an adenosine-dependent warm-up
angina mechanism. In our study, the bolus of aminophylline
was 5 mg/kg followed by a continuous infusion; exercise was
symptom-limited, and inter-test time was about 10 min.
More myocardial ischemia was solicited (maximum STD of
2.50 6 0.98 mm), and there was a significant 15% increase
in ischemic threshold on re-exercise. Thus, in our study, a
robust dose of aminophylline, considered sufficient to an-
tagonize myocardial adenosine receptors nonselectively, did
not block the rise in ischemic threshold nor the decrease in
adjusted maximum STD observed with repeated exercise,
both of which are characteristic of the warm-up phenome-
non. While this does not necessarily rule out any role for
adenosine as a mediator of warm-up ischemia, it makes it
unlikely that adenosine is a critical mediator of this phe-
nomenon.
In warm-up angina, in contrast with experimental isch-
emic preconditioning and during coronary angioplasty (27–
29), activation of K1-ATP also does not appear to be
critically involved (7,30). When this notion is added to the
present evidence that adenosine receptor blockade does not
blunt the warm-up phenomenon, it strongly suggests that
the mechanisms of classic ischemic preconditioning and of
warm-up angina are physiologically distinct.
Potential mechanisms. Interestingly, aminophylline raised
the ischemic threshold of the first exercise in our study
compared with saline, confirming previous studies (31,32).
We also found that its attenuation of adjusted maximum
STD was significantly greater than that observed on re-
exercise with saline. Thus, contrary to the hypothesis tested,
aminophylline appeared to potentiate, not blunt, the
warm-up angina effect. The ischemia-sparing effect of
aminophylline has been attributed to the blocking of trans-
mural coronary steal from ischemic endocardium to nonisch-
emic epicardium, induced by local adenosine release (33–
36). This redistribution of myocardial blood flow effect
could also be achieved by aminophylline’s stimulation of ›1
receptors (37–39). The unexpected finding that the
warm-up angina effect was amplified with aminophylline
raises the possibility that the mechanism of warm-up angina
might be redistributive transmural myocardial flow from
epicardium to endocardium. Such improved perfusion
would not be apparent with Tl-201 SPECT that would
rather detect modifications in extent and severity of isch-
emia due to increased collateral flow from adjacent nonisch-
emic myocardium. If such a mechanism accounts for the
warm-up phenomenon, it would be necessary to postulate
the existence of a local chemical mediator with a half-life of
at least several minutes, liberated under the stimulus of the
first exercise, responsible for the transmural redistribution of
flow and potentiated by aminophylline. An animal model of
the warm-up phenomenon, using microspheres to measure
transmural distribution of myocardial blood flow, would be
necessary to explore this possibility. Finally, aminophylline
might also exert an ischemia-sparing effect via its influence
on substrate metabolism during exercise (40).
Conclusions. The mechanism of ischemic attenuation on
re-exercise or warm-up angina remains elusive. It does not
appear to be explained by improved collateral myocardial
perfusion and, in this regard, resembles classic ischemic
preconditioning. However, it is unaffected by both adeno-
sine receptor blockade and by blockade of K1-ATP (7,30),
suggesting that it is mechanistically distinct from classic
ischemic preconditioning. Future work should determine
whether transmural myocardial flow redistribution or an
ischemia-induced shift in myocardial energy-producing
substrate might not account for this intriguing phenome-
non.
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